To evaluate the efficacy and safety of renal artery (16%) of those whose renal function was normal stents in renovascular disease, we identified 10 initially. Six of 379 (1.6%) patients died within 30 descriptive studies containing sufficient information days of stenting, but in only two (0.5%) was death for systematic evaluation. No randomized comparjudged to be procedure-related. Complications, other isons of stenting with angioplasty or with surgery than those which led to dialysis, occurred in 42/379 were found. Overall, stents were placed in 416 renal (13%) patients, one third requiring intervention, ranarteries in 379 patients, mean age 64 years (range ging from blood transfusion to a surgical bypass pro-27-84), 56% male. Of the stenoses, 97% were cedure. Renal function as judged by serum creatinine atheromatous (inter-study range 71-100%), 80% concentration (SCC) improved in 26%, stabilized in ostial (22-100%) and 31% bilateral (12-87%). The 48% and deteriorated in 26% of patients whose clinical indication for stenting was usually hyperrenal function was impaired initially (SCC tension with or without mild renal impairment.
Introduction
Our understanding of renovascular disease has that bilateral renovascular disease is an important and potentially reversible cause of acute and chronic advanced considerably during the last decade. The reasons for this include a greater appeciation of the renal failure in the elderly12-15 and of recurrent pulmonary oedema16,17 in patients with poorly natural history of both the atherosclerotic and fibromuscular forms of the disease;1-3 the increasing controlled hypertension and renal insufficiency. Unfortunately these advances have not been recognition of athero-embolic disease;4,5 the widespread use of percutaneous transluminal angioplasty mirrored by similar progress in the evaluation of the different forms of treatment. Ramsay, in a penetrating (PTRA)6-8 and the introduction of renal artery stenting;9 the advent of new and more effective techniques review of 10 angioplasty series in 1990, found that selection criteria varied, that blood pressure followfor surgical revascularization;10,11 and the realization up was haphazard and subject to measurement bias, ing. We also extracted data concerning duration of follow-up, complications and death. Technical and that five definitions of cure and 10 definitions of improvement were used. Cures were claimed for aspects were generally more easily retrieved from the 10 papers than clinical outcomes, and four 19% (range 9-29%) of atheromatous and 50% (25-85%) of fibromuscular patients. He concluded authors supplied missing data on request. For the purpose of this analysis, selected baseline data and that 'if these data had been used to support the efficacy of an antihypertensive drug no regulatory outcomes of interest have been presented in tabular form, the results summed and averages obtained. body would have found them acceptable'. 6 Eight years after Ramsay's review of angioplasty, Full details of the information extracted from each of the papers are available from CI. enthusiasm for angioplasty alone in atheromatous disease has begun to wane. This is because a substantial proportion of patients either have an unsatisfactory result through elastic recoil or dissection, or re-present at a later date with restenosis.7
Results
Radiologists now use stents if they fail to achieve a technically successful dilatation with PTRA, and Baseline clinical details some opt for a stent as a primary procedure. Ten
Stents were placed in a total of 416 renal arteries in separate reports of renal artery stenting have been 379 patients ( were used in the 10 studies, the minimum stenosis Three additional early studies of stenting were was 50% in nine, indicating that the great majority of identified but rejected. All three were published in patients had haemodynamically significant lesions 1991. The first reported the results of stenting in (Table 2) . Palmaz stents were used in eight studies, and only 10 patients,28 the second in 11 patients29 and Wallstents in two. The most common radiological the third contained insufficient data for comparative indication for stent placement was failed PTRA. This analysis.30 Studies of both angioplasty and stenting was due to elastic recoil, usually of an ostial stenosis, in which it was not possible to distinguish the results at the time of the procedure in 58%. Two per cent of stenting separately, such as that by Pattynama and were stented for dissections occurring during PTRA, colleagues,31 were also excluded from the analysis. and 15% for restenosis occurring some time after a previous PTRA. Three studies used stents as a primary procedure, accounting for 25% of the stents included
Data extraction
in this review. Technical success, using four criteria that ranged The following data were extracted by systematic review of each paper: country of origin, period of from <50% to <10% residual stenosis, ranged from 96-100%. Restenosis, defined as Á50% study, number of patients including age and gender, the number of vessels stented and the proportion of narrowing in all 10 studies, was evaluated by angiography or doppler in 312/416 (75%) arteries. The stenoses that were atheromatous, ostial and bilateral. Patients with unilateral stenosis and contralateral average time for re-evaluation was relatively short at 6-12 months in 7/10 studies. The overall restenosis occlusion were considered to have bilateral disease. Technical aspects of interest included radiological rate was 49/312 (16%). Restenosis was 30/136 (22%) in the first five studies and 19/176 (11%) in the indications for stenting, type of stent, technical success (% residual stenosis) and restenosis during second five, suggesting improved stent technology and/or radiological expertise with time. Three studies follow-up. Clinical outcomes in each paper were determined from reported measurements of blood reported secondary patency rates in excess of 90% at intervals of up to 5 years in a total of 148 patients pressure and serum creatinine before and after stent- Rec, elastic recoil; Dis, dissection; Res, restenosis; Pri, primary procedure. *Follow-ups are means except **medians.
after 14 had had a second procedure for restenosis. we did not consider the category 'improved' to be sufficiently robust for detailed analysis. Average Most authors felt that restenosis was common enough to justify follow-up and re-intervention. blood pressures during follow up when patients were taking fewer antihypertensive drugs, were lower than immediately before stenting suggesting that, at the Blood pressure very least, stenting had reduced the need for antiHypertension was present in nearly all patients, and hypertensive medication in most patients. was the main clinical reason for stenting in 58% (i.e. those with serum creatinine concentration
Renal function
<133 mmol/l). All ten studies categorized blood pressure after stenting as cured, improved or
Comparison of baseline and follow-up serum creatinine concentrations (SCC) is shown in Table 4 . unchanged. The criterion for cure-diastolic pressure ∏90 mmHg on no therapy-was the same in all ten Overall, 42% patients were considered to have a degree of renal impairment, as judged by baseline studies, but the definition of improvement varied. Blood pressure was cured by stenting in 34/379 (9%) SCC >133 mmol/l (1.5 mg%). Renal function was improved after stenting in 26% of these, deteriorated overall and in 34/207 (16%) of those whose renal function was normal initially (Table 3) . Because none in 26% and remained unchanged in 48%. As a result the average SCC during follow-up was not significof the studies described their technique of blood pressure measurement, gave a formal trial of medical antly different from baseline. One study with a median baseline SCC of 257 mmol/l reported serial therapy before stenting or reported serial measurements of blood pressure before and after stenting, measurements of SCC before and after stenting, and showed that successful stenting can slow the rate of repair (2), guidewire perforation of renal artery leading to surgical bypass (1), stent thrombosis treated progression of renal failure in patients whose renal function is deteriorating beforehand.26 Only 18 (5%) by urokinase (1), distal renal embolus requiring streptokinase (1), dissection of iliac artery which was patients overall had SCC >400 mmol/l initially. Four of these were dialysis-dependent at the time of treated by stenting (1) and septicaemia requiring intravenous antibiotic (1). Complications for which stenting, and two recovered sufficient renal function after stenting to discontinue dialysis, but seven of no specific intervention was required included worsening renal failure that stabilized or recovered the remaining 14 patients (50%) required haemodialysis during follow-up. In all, nine (2.4%) patients without dialysis (12), distal renal embolism or occlusion that was either asymptomatic or caused lumbar started dialysis after stenting. Partial recovery of renal function occurred in two patients, while the other pain only (5), haematoma at puncture site (5), guidewire perforation of renal artery (4), asymptoseven remained dialysis-dependent. Two of the nine died during follow-up. matic stent occlusion (1) and cholesterol embolism to lower limbs (1).
Complications
Six of the 379 (1.6%) patients died within 30 days Discussion of stenting, but in only 2/379 (0.5%) was death judged to have been related to the procedure. The optimal management of renovascular disease remains to be determined. This is partly because this Complications, other than those which led to dialysis, were reported by the authors of the 10 studies in complex condition is a heterogeneous disorder, and partly because clinicians and radiologists have been 42/379 (11%) patients. If the need for dialysis is included, then 51/379 (13.5%) patients may have reluctant to submit their patients to randomized comparisons of treatment. Lack of trial evidence, experienced a complication as a result of stenting, though it is difficult to be certain how many patients however, has not stood in the way of strongly-held opinion, which includes the recent claim that starting dialysis did so as a result of the procedure itself, or by progression of their underlying disease.
'angioplasty is now the accepted first line therapy for renal artery stenosis'.9 Some complications were serious, others less so. The estimates of the frequencies of some complicaTwo randomized trials of intervention by PTRA versus continued medical therapy, conducted in tions must necessarily be regarded as imprecise, given the unsystematic way in which they were Scotland and France, have since been published. In the Scottish study, 27 patients with unilateral and 28 reported. Complications for which specific interventions were required included haemorrhage requiring with bilateral atherosclerotic RAS were randomized separately to PTRA or medical therapy,32 whereas transfusion or drainage (4), femoral artery pseudoaneurysm requiring ultrasound guided compression all 49 patients in the French study had unilateral atherosclerotic RAS.33 Importantly, both trials (3), damage to brachial artery requiring surgical ARF,acute renal failure; CRF, chronic renal failure. Baseline and follow-up creatinine in mmol/l are means except for: 1not given but <176 (Rees et al.) and <164 (Hennequin et al.) from data in papers; 2mean creatinine excluding one patient on haemodialysis; 3median creatinine excluding two patients with CRF; 4median creatinine for whole group at baseline, follow-up reported as change in slope of reciprocal creatinine. Criteria for improvement and deterioration in renal function were Á 10-20% change in creatinine in 7/10 studies. In two studies the change in creatinine was not specified, and in one study the change in creatinine was >18 mmol/l.
included a run-in period on a standardized antiThe recent advent of renal artery stenting seems hypertensive drug regimen. The main findings were:
likely to have reduced rather than enhanced the no difference between the two treatment arms for prospect of further randomized comparisons. None blood pressure control or serum creatinine in patients of the ten studies described in this review have with unilateral RAS, in either study. In the French compared stenting with any other treatment modality, study, small falls in clinic blood pressures were not yet all ten have concluded that stenting is technically confirmed by the more objective 24-h ambulatory feasible, without major complication and an effective blood pressure recordings. Patients with bilateral form of therapy for ostial stenoses. Examination of RAS undergoing PTRA in the Scottish study had the data in these studies suggests that their authors' lower systolic blood pressure during follow-up ( p= confidence in the benefits for blood pressure and 0.02), but no overall change in serum creatinine, an renal function may be misplaced. Cure of hyperunexpected result. The authors of both studies contension may be possible in 16% patients in whom cluded that previous uncontrolled assessments of the clinical indication for stenting is hypertension PTRA overestimated its potential for lowering blood without renal impairment. Methodological problems pressure. A third comparison of PTRA and medical mean that it is difficult to interpret the category of therapy, the Dutch Renal Artery Stenosis 'improved' blood pressure control, but the fact that Co-operative (DRASTIC) Study is due to report in patients were taking fewer antihypertensive medica-1998 (F. Derkx, personal communication).
tions during follow-up, suggests that stenting does at Historically, the main form of intervention in least have a drug-sparing effect. Successful stenting renovascular disease has been surgery, which has may also permit the use of ACE inhibitors, provided many advocates and for which published results are that renal function continues to be monitored at least as good as those reported for angioplasty.
closely.22 Thus, it has been claimed that surgical intervention Overall, renal function did not improve significby aortorenal and more recently hepatorenal or antly after stenting in the patients with renal impairsplenorenal bypass may be an effective form of ment in these ten studies, but nor did it worsen. therapy for renovascular disease with poorly conGiven the natural history of renovascular disease trolled hypertension, progressive renal failure2-4 or which is to progress from unilateral to bilateral, from pulmonary oedema.5,6 The same methodological stenosis to occlusion, and from normal to elevated criticisms apply however: namely frequent failure to creatinine concentration,1 these results might indicate describe the method of blood pressure measurement; that renal function was preserved by stenting. Only absence of a formal trial of medical therapy preone of the ten studies reported serial measurements operatively; and lack of serial measurements of blood of SCC before and after stenting, and this strongly pressure or renal function before and after surgery.
suggested ( Figure 2 ) that successful stenting may slow In the only published randomized comparison of the rate of progression of renal failure in patients PTRA and surgery, 58 low-risk patients (unilateral whose renal function is deteriorating beforehand. RAS, age <70 years, not diabetic and serum creatinThese are however short-term results (median followine <300) were enrolled.34 Secondary patency rates up was 6 months) in a small number of patients. We (after four patients in the PTRA group had an have even less data on patients with more advanced operation and one surgical patient had PTRA) were renal failure. Only 18/379 (5%) patients had baseline similar (97% surgical and 90% PTRA). Using an serum creatinine >400 mmol/l. Two of the four intention-to-treat analysis, 3/29 PTRA and 5/29 patients who were on regular haemodialysis before surgical patients were cured of their hypertension stenting managed to discontinue dialysis, but seven (BP <140/90 on no treatment). The authors conof the remaining fourteen patients (50%) required cluded that PTRA should be the treatment of choice haemodialysis during follow-up (Table 4) . Clearly we for atherosclerotic renal artery stenosis causing renoneed more data on the effects of stenting in patients vascular hypertension, if combined with intensive with severe renal failure. follow up and aggressive re-intervention. They also The price to be paid for these benefits is that conceded during discussion that their patients were 10-15% are likely to restenose within a year of highly selected, and that their results could not be stenting, although with aggressive reintervention extrapolated to the more commonly encountered secondary patency rates of up to 90% at 5 years complex elderly patient with bilateral disease, renal may be possible. A similar proportion of patients insufficiency and atherosclerotic disease at other will experience a complication of stenting, and onesites.34 There has been one other randomized third of these will require some form of further comparison of PTRA and surgery, at Vanderbilt in intervention as a result. Specific therapies will range the 1980s, but this study experienced recruiting from blood transfusion, ultrasound compression of a difficulties, and its findings have never been published (R.H. Dean, personal communication).
pseudoaneurysm, thrombolytic therapy for stent thrombosis, surgical repair or stenting of a damaged renovascular disease and uncontrolled hypertension, advancing renal failure or pulmonary oedema. If vessel through to a surgical bypass procedure. Fortunately procedure-related deaths are very coupled with a greater commitment to managing patients by agreed protocols, this approach would uncommon, at <1%.
Where do these findings leave renal artery stenting undoubtedly yield useful descriptive data on the clinical outcome of stenting. Such a strategy is clearly in the management of renovascular disease? The time is ripe for a carefully designed large-scale a compromise, but does at least have the attraction of limiting a potentially invasive procedure to those randomized comparison of percutaneous renal angioplasty with or without stenting plus best medical at highest risk of an event if left untreated, on the grounds that they are likely to have the most to gain treatment versus best medical treatment alone, in high-risk patients with renovascular disease who are by successful treatment. It is also supported by reports indicating that worthwhile improvements in considered suitable for both forms of intervention. Such a study will shortly begin recruiting patients renal function36-39 and pulmonary oedema16,17 are possible in selected patients. and will include a second randomization between angioplasty alone and angioplasty with stenting for those randomized to the intervention group. 35 In the continuing absence of a randomized comparison,
